Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer
Signal Transduct Target Ther
.
2019 Nov 29:4:52.
doi: 10.1038/s41392-019-0088-z.
eCollection 2019.
Authors
Yan Wang
#
1
,
Rongjie Lin
#
1
2
,
Huan Ling
1
,
Yuan Ke
1
,
Yangyang Zeng
1
,
Yudi Xiong
1
,
Qian Zhou
1
,
Fuxiang Zhou
1
3
,
Yunfeng Zhou
1
3
Affiliations
1
Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, China.
2
2Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
3
3Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
#
Contributed equally.
PMID:
31815009
PMCID:
PMC6882822
DOI:
10.1038/s41392-019-0088-z
No abstract available
Keywords:
Cancer therapy; Gastrointestinal cancer.
Publication types
Research Support, Non-U.S. Gov't